DGAP-Adhoc

AEVIS Holding SA: Substantial increase of revenues and operating profit in first half-year 2014

AEVIS Holding SA / Key word(s): Interim Report

30.09.2014 07:15

Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------

AEVIS Holding SA (AEVIS) today published its Half Year Report 2014. The
company made a significant step forward in the implementation of its growth
strategy with the build-up of a third pillar of activities. The integration
of the luxury hotel chain Victoria-Jungfrau Collection AG (VJC) in
combination with further acquisitions by Genolier Swiss Medical Network
(GSMN) and Swiss Healthcare Properties (SHP) resulted in improved results
in the first half of 2014. Total revenues increased to CHF 268.9 million,
up by 24.0% from the previous year. Based on an unchanged portfolio,
organic growth amounted to 3.6% in the reporting period. The EBITDA soared
to CHF 36.3 million or 13.5% of revenues and the profit for the period
under review amounted to CHF 3.0 million. AEVIS expects to realise a pro
forma turnover of approximately CHF 600 million in 2014 with the current
perimeter (all entities consolidated over a 12 month period, including VJC)
and will focus on improving the EBITDA of its entities by 1.5% to 3% per
year.

At the end of the first half of 2014, AEVIS announces total revenues of CHF
268.9 million, up 24.0% compared to the same period last year (CHF 216.9
million). Even though this increase is mainly due to acquisitions and the
integration of a new pillar of activities, organic growth still amounts to
3.6% compared to the same portfolio last year. EBITDA soared to CHF 36.3
million (CHF 24.7 million) or 13.5% of revenues. The profit for the period
under review amounted to CHF 3.0 million compared to CHF 4.9 million a year
ago. The decrease in net profit is mainly due to increased amortisations
and financial expenses following substantial investments by SHP and into
various GSMN clinics, the integration of VJC as well as the issuance of a
further bond.

Genolier Swiss Medical Network bolsters market position
GSMN continues to account for the majority of revenues achieved within
AEVIS. After the successful integration of Schmerzklinik Basel in January
2014, a total turnover of CHF 237.1 million, 14.4% more than in the
previous year, was achieved in the reporting period. Organic growth
amounted to 3.1% in the first six months of 2014. GSMN has acquired a
majority stake in Visionplus SA, Lausanne, and wishes to develop an
activity in ophthalmic medicine and surgery. The company, renamed Genolier
Swiss Visio Network, is active in the field of ophthalmology, mainly at